press_release_conclusion: A new malaria vaccine has been created to target different forms of the disease and help those most at risk.
abstract_conclusion: MSP-1 hybrid is immunogenic in experimental animals using adjuvants suitable for human use, eliciting antibodies against epitopes from all three Block 2 serotypes.